Remove 2022 Remove Safety Remove Treatment
article thumbnail

The Scott of Pot At It Again. Cann Group aiming for over-the-counter CBD approval in late 2022

Cannabis Law Report

Phase I clinical trial of the Satipharm CBD capsules in which results demonstrated the safety and high performance of the oral capsule technology, including the superior delivery profile of cannabidiol (CBD) compound to trial subjects. The treatment was generally well tolerated and the median reduction in seizures was 81.9%

article thumbnail

Michigan Cannabis Industry Must Be Prepared for Environmental, Health, and Safety Compliance Inspections from EGLE and MIOSHA

Dykema (Cannabis Law Blog)

As the Michigan cannabis industry continues to grow and mature, medical and adult-use licensees would be well served to take proactive steps to ensure compliance with Environmental, Health and Safety (EHS) regulations. Indeed, in November 2021, the MRA sent a voluntary survey to licensed processors across the State of Michigan.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Behind the Buds: Examining Job Conditions in the Cannabis Cultivation Industry

Veriheal

In January 2022, a devastating incident shook the U.S. It demonstrates the urgent need for increased awareness and safety measures to protect workers in this evolving field. Here’s what happened and what it could mean for the future of cannabis cultivation safety. By January 2022, her respiratory issues had worsened.

article thumbnail

CBD Market Report

Project CBD

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Available at: [link] Accessed October 17, 2022. February 2, 2022.

CBD 144
article thumbnail

Progress for Patients in Washington, D.C.: Residents Ages 21+ Can Temporarily Self-Certify

Veriheal

On July 6, 2022, Washington, D.C. The Medical Marijuana Self-Certification Temporary Amendment Act of 2022 currently permits D.C. law—specifically, the Legalization of Marijuana for Medical Treatment Initiative of 1999—for a total of 225 days. implemented a revolutionary emergency amendment to its medical cannabis program.

article thumbnail

Study Demonstrates Power of Using Ketamine for Parkinson’s Disease

Veriheal

Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Specifically, the group focused on ketamine’s ability to relieve the side effects of a common treatment called Levodopa.

article thumbnail

District of Columbia Provides Employment Protections to Cannabis Users

The Blunt Truth

Last month, on July 13, 2022, Washington, D.C. Mayor Muriel Bowser signed the “ Cannabis Employment Protections Amendment Act of 2022 ” (D.C. The District of Columbia legalized cannabis for medicinal purposes in 2010 and began to permit individuals to use the drug recreationally in 2015.

Safety 111